AH

Abdul Hameed Veeran Sauriamparambil

Director Director DIN 03111862
DIN 03111862 First appointment Oct 2010 Primary industry Real Estate and Construction
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Hameed Veeran Sauriamparambil

Data last updated:

Abdul Hameed Veeran Sauriamparambil was a Director at Al Marai Projects And Properties Private Limited (2010–2012) and Director at Biomint Pharmaceuticals Private Limited (from 2014). The companies operate in Real Estate and Construction.

DIN 03111862
Primary Designation Director
Industry Real Estate and Construction
First Appointment 13 Oct 2010
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Oct 20102010Strike Off
Director16 Mar 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biomint Pharmaceuticals Private Limited
Al Marai Projects And Properties Private Limited
Premium access

Shareholding and investment profile for Abdul Hameed Veeran Sauriamparambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Hameed Veeran Sauriamparambil

Abdul Hameed Veeran Sauriamparambil was first appointed on 13 Oct 2010 as Director at Al Marai Projects And Properties Private Limited. The most recent appointment on record is 16 Mar 2014 at Biomint Pharmaceuticals Private Limited.

Abdul Hameed Veeran Sauriamparambil held 2 earlier board appointments: Al Marai Projects And Properties Private Limited (Director, 13 Oct 2010 to 02 Jul 2012); Biomint Pharmaceuticals Private Limited (Director, from 16 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available